Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture
暂无分享,去创建一个
[1] D. V. van Thiel,et al. Clonal lines of human choriocarcinoma cells in culture. , 1971, Acta endocrinologica. Supplementum.
[2] R. Hussa,et al. Macromolecular synthesis is required for stimulation of estrogen synthetase activity by dibutyryl cyclic AMP plus theophylline in choriocarcinoma cell culture , 1981, Steroids.
[3] W. Wouters,et al. Aromatase in the human choriocarcinoma JEG-3: Inhibition by R 76 713 in cultured cells and in tumors grown in nude mice , 1991, The Journal of Steroid Biochemistry and Molecular Biology.
[4] Leslie J. Browne,et al. In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A , 1987, Steroids.
[5] I. Khan,et al. Mechanism for control of hydroxymethylglutaryl-coenzyme A reductase and cytochrome P-450 side chain cleavage message and enzyme in the corpus luteum. , 1990, Endocrinology.
[6] J. Kitawaki,et al. Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: A new system for aromatase inhibitor screening , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[7] A. Brodie,et al. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. , 1977, Endocrinology.
[8] B. Metcalf,et al. Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue culture. , 1984, Journal of steroid biochemistry.
[9] D. Pompon,et al. Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Satoh,et al. Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. , 1967, The Journal of clinical endocrinology and metabolism.
[11] A. Brodie,et al. Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. , 1996, Endocrinology.
[12] R. Brueggemeier,et al. Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cell cultures. , 1990, Cancer research.
[13] H. Brodie,et al. Studies on the mechanism of estrogen biosynthesis. 8. The development of inhibitors of the enzyme system in human placenta. , 1973, Endocrinology.
[14] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[15] D. Dabbs,et al. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. , 1996, Endocrinology.
[16] C. Mendelson,et al. Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[18] M. Ascoli,et al. Characterization of steroid production in cultured human choriocarcinoma cells. , 1981, The Journal of clinical endocrinology and metabolism.
[19] W. Chan,et al. Aminoglutethimide augments follicle-stimulating hormone-induced aromatase activity in cultured porcine granulosa cells. , 1988, Endocrinology.
[20] S. Bates,et al. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. , 1990, Biochemistry.
[21] Thompson Ea,et al. The Involvement of Human Placental Microsomal Cytochrome P-450 in Aromatization , 1974 .
[22] D. Covey,et al. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione. , 1982, Molecular pharmacology.
[23] M. Dowsett,et al. Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. , 1989, Cancer research.
[24] Shiuan Chen,et al. Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala and their interactions with aromatase inhibitors , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[25] R. Koos,et al. Expression of basic fibroblast growth factor in the rat ovary: detection of mRNA using reverse transcription-polymerase chain reaction amplification. , 1989, Molecular endocrinology.
[26] R. Hussa,et al. Estrogen synthetase in choriocarcinoma cell culture. stimulation by dibutyryl cyclic adenosine monophosphate and theophylline , 1978, Steroids.
[27] C. Tsai-Morris,et al. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo , 1981, Steroids.
[28] G. Farrell,et al. Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide. , 1993, The Journal of pharmacology and experimental therapeutics.
[29] M. Dowsett,et al. Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy. , 1984, The Journal of clinical endocrinology and metabolism.